Noncytotoxic Vesicant Medications and Solutions

INS established a vesicant task force with the goal of developing an evidence-based list of noncytotoxic vesicant medications/solutions.

Outside of oncology practice, there is not a list of noncytotoxic vesicants as established by a professional­ organization. ­INS ­identified ­the ­need ­to ­­address ­this ­gap ­based on ­the­ following­ premise:­the­ first­ step ­in­ preventing ­extravasation ­is ­the ­identification ­and ­recognition ­of ­vesicant­ drugs and solutions.

The scope of work was limited to creating an evidence-based list of noncytotoxic vesicant medications/solutions and developing an extravasation checklist that outlines risk reduction strategies including early recognition of signs and symptoms of extravasation.

Key:

Complete
Failed
Available
Locked
Noncytoxic Vesicant Medications and Solutions